arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2202.03487cs.LG
收藏

Targeted-BEHRT:面向纵向电子健康记录观察性因果推断的深度学习

Targeted-BEHRT: Deep learning for observational causal inference on longitudinal electronic health records

University of Oxford(牛津大学)

Shishir Rao, Mohammad Mamouei, Gholamreza Salimi-Khorshidi, Yikuan Li, Rema Ramakrishnan, Abdelaali Hassaine, Dexter Canoy, Kazem Rahimi

AI总结:

本文提出结合双重稳健估计的Transformer模型Targeted BEHRT,在高维纵向EHR上估计降压药与新发癌症风险的零因果关联,并在半合成实验中取得优于基准的RR估计。

摘要:

当随机临床试验(RCT)不可行或无法推广时,观察性因果推断有助于医学决策。然而,传统方法在实践中无法给出无混杂的因果结论。“双重稳健”非参数工具的兴起,加上用于捕捉多模态数据丰富表示的深度学习的发展,为在综合电子健康记录(EHR)上开发并测试此类因果推断模型提供了独特机遇。本文研究一个由RCT确立的零因果关联的因果建模:降压药使用对新发癌症风险的影响。我们为观察性研究构建了一个数据集,并开发了基于Transformer的模型Targeted BEHRT,结合双重稳健估计,估计平均风险比(RR)。在由该数据集派生、具有不同类型和强度混杂的多个半合成实验中,我们将模型与用于因果推断的基准统计模型和深度学习模型进行比较。为进一步检验方法可靠性,我们还在数据有限的情形下测试模型。结果表明,在各实验的高维EHR风险比估计中,与基准相比,我们的模型给出了更准确的RR估计(相对于真实值的绝对误差和最小)。最后,我们将模型应用于原始案例研究,即降压药对癌症的影响,并证明模型总体上捕捉到了已被验证的零关联。

英文摘要:

Observational causal inference is useful for decision making in medicine when randomized clinical trials (RCT) are infeasible or non generalizable. However, traditional approaches fail to deliver unconfounded causal conclusions in practice. The rise of "doubly robust" non-parametric tools coupled with the growth of deep learning for capturing rich representations of multimodal data, offers a unique opportunity to develop and test such models for causal inference on comprehensive electronic health records (EHR). In this paper, we investigate causal modelling of an RCT-established null causal association: the effect of antihypertensive use on incident cancer risk. We develop a dataset for our observational study and a Transformer-based model, Targeted BEHRT coupled with doubly robust estimation, we estimate average risk ratio (RR). We compare our model to benchmark statistical and deep learning models for causal inference in multiple experiments on semi-synthetic derivations of our dataset with various types and intensities of confounding. In order to further test the reliability of our approach, we test our model on situations of limited data. We find that our model provides more accurate estimates of RR (least sum absolute error from ground truth) compared to benchmarks for risk ratio estimation on high-dimensional EHR across experiments. Finally, we apply our model to investigate the original case study: antihypertensives' effect on cancer and demonstrate that our model generally captures the validated null association.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑